Quantum Biopharma Ltd.

QNTM Nasdaq SEC CIK 1771885
Follow Quantum Biopharma Ltd. Weekly email: filings, results

Financials

Reported figures only · latest: fiscal 2025 USD · IFRS
EPS, diluted -
Operating cash flow −$8.2M −19.8% vs prior year
Operating income −$15.3M +5.2% vs prior year
Net income by fiscal year
−$31.8M
−$35.3M
−$23.6M
FY20 FY21 FY22

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, IFRS
Revenue and net income8 fiscal years
−$40M−$30M−$20M−$10M$0FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearNet income
FY25-
FY24-
FY23-
FY22−$23.6M
FY21−$35.3M
FY20−$31.8M
FY19−$39.1M
FY18-
Free cash flowOperating cash flow minus capital expenditure
−$30M−$20M−$10M$0FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25-
FY24−$6.9M
FY23−$10.8M
FY22−$28.4M
FY21−$20.7M
FY20−$19.1M
FY19-
FY18-